Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Hematology

What Does a High LDH Mean in DLBCL, and What Causes It?

At a Glance

In DLBCL, high LDH is a nonspecific finding that may reflect rapid lymphoma cell turnover, treatment effects, exercise, infection, organ injury, or a damaged blood sample. It does not prove the lymphoma is growing or has returned; doctors interpret it with trends, symptoms, and other tests.

A high Lactate Dehydrogenase (LDH) level in Diffuse Large B-Cell Lymphoma (DLBCL) can be associated with increased cell turnover, but minor day-to-day fluctuations in your patient portal are rarely a cause for panic. Because LDH is an enzyme found in almost every cell in your body, an elevated result is a very non-specific finding [1]. While your oncology team tracks it as part of a broader clinical picture, many non-cancerous factors—from a difficult blood draw to a recent workout—can cause temporary spikes in your LDH [2]. A high LDH does not by itself show that your lymphoma is growing or returning.

What is Lactate Dehydrogenase (LDH)?

Lactate Dehydrogenase (LDH) is an enzyme that helps your cells produce energy [3]. It is present in almost all tissues, including your muscles, liver, heart, and red blood cells.

When cells are damaged, destroyed, or dividing rapidly, they release LDH into the bloodstream. Because of this, a blood test for LDH acts as a general marker of cellular stress, tissue injury, or inflammation anywhere in the body, not just a specific marker for lymphoma [1].

How Doctors Use LDH in DLBCL

Your doctors will interpret your LDH levels differently depending on where you are in your treatment journey:

1. At Diagnosis (The IPI Score)

Before you begin treatment, an elevated LDH (above your specific laboratory’s upper limit of normal) is used as a prognostic marker. Rapidly dividing DLBCL cells turn over quickly and release LDH into the blood, meaning higher baseline levels can correlate with a higher tumor burden and more aggressive tumor biology [4][5].

LDH is one of the five key components of the International Prognostic Index (IPI), a scoring system oncologists use to evaluate your baseline risk and help tailor your treatment [6][7][8]. The classic IPI considers:

  • Age over 60
  • LDH above the laboratory’s upper limit of normal
  • Ann Arbor Stage III or IV disease
  • ECOG Performance Status of 2 or higher (which measures how much your daily activities are restricted)
  • More than one extranodal site (lymphoma outside the lymph nodes)

The IPI is a pretreatment tool that estimates statistical risk groups. It does not dictate your individual outcome or single-handedly determine your treatment plan. (Note: Some observational research has explored combining LDH with albumin levels for prognostication, but this is not currently part of the standard IPI or routine clinical practice [9]).

2. During Treatment

During active chemotherapy regimens like R-CHOP, LDH levels can fluctuate. As chemotherapy destroys lymphoma cells, LDH may temporarily rise.

Important Safety Warning: If you are actively receiving treatment and have a high tumor burden, a sudden spike in LDH alongside changes in kidney function, potassium, and uric acid can be a sign of Tumor Lysis Syndrome (TLS), a medical emergency caused by cancer cells breaking down too quickly. Additionally, if you develop a fever of 100.4°F (38.0°C) or higher during chemotherapy, contact your oncology team or emergency services immediately—do not wait for your next LDH test or appointment to report a fever.

3. Post-Treatment Surveillance

After treatment, your doctor will monitor your bloodwork for persistent trends rather than minor isolated jumps. However, it is important to know that DLBCL can relapse without any rise in LDH, and an elevated LDH can occur without a lymphoma relapse. You should never use LDH as a standalone cancer test.

Why You Shouldn’t Panic Over Minor Fluctuations

An elevated LDH does not automatically mean your lymphoma is active. Because LDH is found in so many different tissues, many everyday occurrences and non-cancerous conditions can cause it to rise [2]:

  • In-Vitro Hemolysis: This is a very common reason for a falsely high LDH. If red blood cells break apart inside the test tube during a difficult blood draw or during transport (in-vitro hemolysis), they spill their LDH into the sample. Your lab will often flag the specimen if this occurs, and your doctor may simply ask for a repeat test. (This is different from hemolytic anemia, which is true red blood cell breakdown inside your body).
  • Exercise and Muscle Strain: Strenuous physical activity or a muscle injury can cause your muscles to release LDH into the blood.
  • Infections and Inflammation: Illnesses like pneumonia or COVID-19 cause inflammatory stress that can significantly elevate LDH levels [1][10].
  • Medications: Certain treatments, such as growth factor injections (like G-CSF) used to boost white blood cells, can cause short-term increases in LDH [11].
  • Organ Injury: Liver disease, heart conditions, or kidney stress can also raise your LDH.

When to Contact Your Care Team

Instead of managing anxiety over patient portal updates alone, agree on a communication plan with your oncology team. You should contact them if you see a marked or persistent rise in your LDH, or if you experience any of the following symptoms (even if your LDH is normal):

  • Unexplained fevers (always treat a fever during active chemotherapy as an emergency)
  • Drenching night sweats
  • Unintentional weight loss
  • New, growing, or painless lumps (lymph nodes)
  • Severe, sudden fatigue, shortness of breath, or confusion

Always follow your oncology team’s specific monitoring plan. They interpret your bloodwork within the broader context of your laboratory reference ranges, symptoms, physical exams, and imaging.

Common questions in this guide

Does a high LDH mean my DLBCL is growing or back?
No. LDH is found in nearly every tissue, so an elevated result can reflect lymphoma cell turnover, infection, inflammation, exercise, organ injury, medication effects, or a blood sample damaged during collection. DLBCL can relapse without an LDH rise, and an elevated LDH alone does not diagnose relapse.
What LDH level is considered high in DLBCL?
A result is generally considered elevated when it is above the upper limit of normal listed by that laboratory; reference ranges can differ. Doctors interpret the number with your baseline, symptoms, examination, imaging, and other blood tests rather than using one universal cutoff.
How does LDH affect the IPI score for DLBCL?
Before treatment, LDH above your laboratory’s upper limit of normal is one of five factors in the classic International Prognostic Index. The IPI also considers age, stage, performance status, and the number of extranodal sites, and it estimates statistical risk groups rather than predicting one person’s outcome.
Can chemotherapy make LDH rise temporarily?
Yes. During chemotherapy such as R-CHOP, LDH can temporarily increase as lymphoma cells break down. A sudden rise together with worsening kidney function or changes in potassium and uric acid may signal tumor lysis syndrome, which requires urgent medical attention.
What can raise LDH besides DLBCL?
An LDH result can rise after strenuous exercise or muscle injury, with infections or inflammation, after some medications such as G-CSF, or with liver, heart, or kidney injury. A difficult blood draw can also break red blood cells in the tube and falsely raise the reported result; your team may recommend repeating the test.
When should I contact my oncology team about a high LDH?
Contact your team about a marked or persistent rise, especially if you have new lymph-node lumps, drenching night sweats, unexplained weight loss, severe fatigue, shortness of breath, or confusion. During active chemotherapy, a fever of 100.4°F (38°C) or higher needs immediate contact with your oncology team or emergency services rather than waiting for the next appointment.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my baseline IPI score, and how does my initial LDH level factor into my overall risk assessment?
  2. 2.Does this lab result show a meaningful trend compared to my baseline, or is it a minor fluctuation?
  3. 3.Should this bloodwork be repeated to check if the sample was hemolyzed during the blood draw?
  4. 4.What specific symptoms or changes in my bloodwork should prompt me to call the clinic or go to the emergency room?
  5. 5.What is our monitoring plan for my LDH levels during and after my treatment for DLBCL?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantation.

    Muchtar E, Dispenzieri A, Lacy MQ, et al.

    British journal of haematology 2017; (178(6)):888-895 doi:10.1111/bjh.14830.

    PMID: 28699650
  2. 2

    Lactate dehydrogenase in dermatology practice.

    Livesey A, Garty F, Shipman AR, Shipman KE

    Clinical and experimental dermatology 2020; (45(5)):539-543 doi:10.1111/ced.14134.

    PMID: 31755143
  3. 3

    The determinants of metabolic discrepancies in aerobic glycolysis: Providing potential targets for breast cancer treatment.

    Littleflower AB, Parambil ST, Antony GR, Subhadradevi L

    Biochimie 2024; (220()):107-121 doi:10.1016/j.biochi.2024.01.003.

    PMID: 38184121
  4. 4

    Hyperpolarized 13C pyruvate magnetic resonance spectroscopy for in vivo metabolic phenotyping of rat HCC.

    Bliemsrieder E, Kaissis G, Grashei M, et al.

    Scientific reports 2021; (11(1)):1191 doi:10.1038/s41598-020-80952-4.

    PMID: 33441943
  5. 5

    Elevated pretreatment serum lactate dehydrogenase level predicts inferior overall survival and disease-free survival after resection of thymic carcinoma.

    Liu Q, Fu X, Su X, et al.

    Journal of thoracic disease 2017; (9(11)):4550-4560 doi:10.21037/jtd.2017.10.86.

    PMID: 29268525
  6. 6

    Central Nervous System Involvement in Patients with Diffuse Large B Cell Lymphoma: Analysis of the Risk Factors and Prognosis from a Single-Center Retrospective Cohort Study.

    Ma J, Li Q, Shao J, et al.

    Cancer management and research 2019; (11()):10175-10185 doi:10.2147/CMAR.S225372.

    PMID: 31819650
  7. 7

    Delineating outcomes of patients with diffuse large b cell lymphoma using the national comprehensive cancer network-international prognostic index and positron emission tomography-defined remission status; a population-based analysis.

    Bishton MJ, Hughes S, Richardson F, et al.

    British journal of haematology 2016; (172(2)):246-54 doi:10.1111/bjh.13831.

    PMID: 26577576
  8. 8

    The Application of the Lymphoma International Prognostic Index to Predict Venous Thromboembolic Events in Diffuse Large B-Cell Lymphoma Patients.

    Abdel-Razeq H, Ma'koseh M, Abdel-Razeq R, et al.

    Frontiers in oncology 2021; (11()):677776 doi:10.3389/fonc.2021.677776.

    PMID: 34123847
  9. 9

    Prognostic value of lactate dehydrogenase, serum albumin and the lactate dehydrogenase/albumin ratio in patients with diffuse large B-cell lymphoma.

    Wu W, Miao L, Zhao L, et al.

    Hematology (Amsterdam, Netherlands) 2024; (29(1)):2293514 doi:10.1080/16078454.2023.2293514.

    PMID: 38108323
  10. 10

    Elevated lactate dehydrogenase predicts pneumonia in spontaneous intracerebral hemorrhage.

    Xiao Y, He S, Cheng X, et al.

    Heliyon 2024; (10(4)):e26109 doi:10.1016/j.heliyon.2024.e26109.

    PMID: 38404841
  11. 11

    Transient increase in lactate dehydrogenase after granulocyte colony-stimulating factor administration during chemotherapy in a patient with advanced seminoma.

    Takeda S, Kawamura S, Tanaka T, Tochigi T

    IJU case reports 2019; (2(1)):34-36 doi:10.1002/iju5.12033.

    PMID: 32743368

This page is for informational purposes only and does not constitute medical advice. Your oncology team should interpret your LDH result in context and tell you when a fever or other symptoms require urgent care.

Get notified when new evidence is published on Diffuse large B-cell lymphoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.